| P50 | author | Fatma Eskioğlu | Q117812994 |
| | Selda Pelin Kartal Durmazlar | Q117813002 |
| P2093 | author name string | Ahmet Akgul | |
| P2860 | cites work | Human chemokines: an update | Q28237635 |
| | Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model | Q28360470 |
| | Homocysteine and vascular disease | Q33705868 |
| | Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis | Q34160359 |
| | Impaired homocysteine metabolism and atherothrombotic disease | Q34249956 |
| | Homocysteine in myointimal hyperplasia | Q34465855 |
| | Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis | Q34974714 |
| | Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease | Q35553528 |
| | Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease | Q35589771 |
| | Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease | Q35609440 |
| | Current concepts in the etiology and treatment of Behçet disease | Q36168752 |
| | C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients | Q38493334 |
| | Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. | Q40713770 |
| | Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. | Q41576959 |
| | Immunopharmacology: immunomodulation and immunotherapy | Q41660285 |
| | Impaired haemostatic kinetics and endothelial function in Behçet's disease | Q42526978 |
| | Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells | Q43912991 |
| | Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion | Q43957611 |
| | Coagulation parameters and plasma total homocysteine levels in Behcet's disease | Q44092042 |
| | Is there an association of plasma homocysteine levels with vascular involvement in patients with Behçet's syndrome? | Q44172996 |
| | Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease | Q44252125 |
| | Serum homocysteine level is higher in Behçet’s disease with vascular involvement | Q44637427 |
| | Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy? | Q44825077 |
| | Vascular endothelial function and plasma homocysteine levels in Behcet's disease | Q45027835 |
| | Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia | Q46719936 |
| | Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients. | Q46840982 |
| | The Behcet's disease activity index | Q47724172 |
| | Homocysteine: an activity marker in Behçet's disease? | Q47872873 |
| | Hyperhomocysteinaemia in Behçet's disease. | Q51548508 |
| | Hyperhomocysteinemia and venous thrombosis: a meta-analysis. | Q51565947 |
| | Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. | Q51567091 |
| | Behçet's disease: evaluation of a new instrument to measure clinical activity. | Q52865109 |
| | Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study | Q57232023 |
| | Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease | Q68086434 |
| | Vascular involvement in Behçet's disease | Q68112962 |
| | Homocystinemia. Vascular injury and arterial thrombosis | Q68342307 |
| | Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons | Q71097689 |
| | Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease | Q71570276 |
| | Vitamin status and intake as primary determinants of homocysteinemia in an elderly population | Q72305071 |
| | Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease | Q73664506 |
| | Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo | Q74583474 |
| | Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease | Q79628198 |
| | A proinflammatory state is associated with hyperhomocysteinemia in the elderly | Q81023743 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | pathogenesis | Q372016 |
| | Behçet's disease | Q911427 |
| P304 | page(s) | 407972 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation | |
| P478 | volume | 2008 | |